|
Market Closed -
Nasdaq
16:00:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 30.00 USD | +7.64% |
|
+12.28% | -95.52% |
| 10-09 | Quince Therapeutics Changes Name to IRulya Therapeutics | MT |
| 10-09 | Quince Therapeutics, Inc. Announces Management and Committee Changes, Effective October 8, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IRLA | Delayed | |
CBOE
| IRLA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bearish |
| Resistance | 32.4 | 34.57 | 109.74 |
| Spread/Res. | -7.41% | -13.22% | -72.66% |
| Spread/Supp. | +12.28% | +25.00% | +87.50% |
| Support | 26.72 | 24 | 16 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IRLA Stock
- Charts IRulya Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
